Preview

Сибирский научный медицинский журнал

Advanced search

Parainfectious opsoclonus-myoclonus syndrome in a child on the example of a clinical case. Results of observation over 5 years

https://doi.org/10.18699/SSMJ20250322

Abstract

   Opsoclonus-myoclonus syndrome is a rare symptom complex, the development of which can be induced by various factors, including infectious and oncopathology, and lead to persistent neurological deficiency, which requires timely diagnosis, treatment and long-term monitoring by specialists of various profiles. In the presented clinical case, a 2-year-old child developed a neurological syndrome in the form of a characteristic combination of opsoclonus, myoclonus, ataxia, psycho-emotional and insomnia disorders after immunization and non-specific general infectious manifestations. Stable clinical remission was achieved against the background of immunosuppressive therapy. Long-term observation for 5 years showed restoration of lost functions of the nervous system and rates of psychomotor development. The need for a comprehensive study of the long-term consequences of parainfectious opsoclonus-myoclonus syndrome is determined by the risk of developing persistent neurological deficit, developing other immunopathological conditions, relapse, and oncopathology. Diagnosis and determination of a treatment strategy for this disease in children is a complex interdisciplinary problem that requires long-term interaction and continuity of specialists of various profiles.

About the Authors

I. F. Fedoseeva
Kemerovo State Medical University of Minzdrav of Russia
Russian Federation

Irina F. Fedoseeva, candidate of medical sciences

650056; Voroshilova st., 22a; Kemerovo



T. V. Poponnikova
Kemerovo State Medical University of Minzdrav of Russia
Russian Federation

Tatiana V. Poponnikova, doctor of medical sciences, professor

650056; Voroshilova st., 22a; Kemerovo



E. N. Urban
Kuzbass Regional Clinical Hospital named after S.V. Belyaev
Russian Federation

Elena N. Urban

650061; Oktyabrsky ave., 22; Kemerovo



A. V. Goncharenko
Kemerovo State Medical University of Minzdrav of Russia
Russian Federation

Alexey V. Goncharenko, candidate of medical sciences

650056; Voroshilova st., 22a; Kemerovo



References

1. Meira A.T., de Moraes M.P.M., Ferreira M.G., Franklin G.L., Rezende Filho F.M., Teive H.A.G., Barsottini O.G.P., Pedroso J.L. Immune-mediated ataxias: Guide to clinicians. Parkinsonism Relat. Disord. 2023;117:105861. doi: 10.1016/j.parkreldis.2023.105861

2. Bhatia P., Heim J., Cornejo P., Kane L., Santiago J., Kruer M.C. Opsoclonus-myoclonus-ataxia syndrome in children. J. Neurol. 2022;269(2):750–757. doi: 10.1007/s00415-021-10536-3

3. Pranzatelli M.R., Tate E.D., McGee N.R. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children. Pediatr. Blood. Cancer. 2018;65(8):e27097. doi: 10.1002/pbc.27097

4. Hsu M., Tejani I., Shah N., Olaosebikan R., Kumar A., Naik S. Review of opsoclonus-myoclonus ataxia syndrome in pediatric patients. Children (Basel). 2024;11(3):367. doi: 10.3390/children11030367

5. Monzani N.A., Corsello A., Tagliabue C., Pinzani R., Mauri E., Agostoni C., Milani G.P., Dilena R. Early acute cerebellar ataxia after meningococcal B vaccine: a case report of a 7-month-old infant and a review of the literature. Ital. J. Pediatr. 2023;49(1):61. doi: 10.1186/s13052-023-01480-1

6. Gurkas E., Gucuyener K., Yılmaz U., Havalı C., Demir E. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis. Pediatr. Int. 2014;56(6):e86–e87. doi: 10.1111/ped.12433

7. Syrbe S., Merkenschlager A., Bernhard M.K., Grosche J., Liebert U.G., Hirsch W., Härtig W. Opsoclonus-myoclonus syndrome after adenovirus infection. Springerplus. 2015;4:636. doi: 10.1186/s40064-015-1429-1

8. Shah N.S., Pathak J., Shah P.C., Bharmal U.F., Ansari M.I. A rare case of opsoclonus myoclonus ataxia syndrome post viral illness. Cureus. 2023;15(6):e40396. doi: 10.7759/cureus.40396

9. Adamaszek M., Langner S., Mehrholz J., Heiinrich A. Opsoclonus-myoclonus-ataxia syndrome due to Covid-19. Cerebellum. 2024;23(3):1245–1248. doi: 10.1007/s12311-023-01610-9

10. Yang J.C., Zekavaty S., Rossi R.D., Mahmoud S.Y. Unique magnetic resonance imaging findings in opsoclonus-myoclonus syndrome secondary to the West Nile virus. Cureus. 2024;16(8):e67932. doi: 10.7759/cureus.67932

11. Bhalodiya D., Rathore C., Gupta V., Prakash S., Pathak K. “Dancing eye, dancing feet” in cerebral malaria: A rare association. Neurol. India. 2018;66(2):543–545. doi: 10.4103/0028-3886.227326

12. Cardesa-Salzmann T.M., Mora J., García Cazorla M.A., Cruz O., Muñoz C., Campistol J. Epstein–Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors. Pediatr. Blood. Cancer. 2006;47(7):964–967. doi: 10.1002/pbc.20573

13. Cannilla H., Messe M., Girardin F., Borruat F.X., Bally J.F. Drug- and toxin-induced opsoclonus – a systematized review, including a case report on amantadine-induced opsoclonus in multiple system atrophy. Tremor Other Hyperkinet. Mov. (NY). 2024;14:23. doi: 10.5334/tohm.832

14. Desai J., Mitchell W.G. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome. J. Child. Neurol. 2012;27(11):1482–1488. doi: 10.1177/0883073812450318

15. Fedoseeva I.F., Goncharenko A.V., Poponnikova T.V., Glebova I.V., Pinevich O.S., Goncharenko V.A. Paraneoplastic opsoclonus-myoclonus syndrome. Zhurnal nevrologii i psikhiatrii imeni Sergeya Sergeevicha Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):165–170. [In Russian]. doi: 10.17116/jnevro2024124121165

16. Fedoseeva I.F., Poponnikova T.V., Galieva G.Yu., Ilyasova O.V. Clinical observations of late infantile and juvenile forms of Niemann – Pick disease type C. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2017;16(3):210–217. [In Russian]. doi: 10.20538/1682-0363-2017-3-210-217

17. Rossi M., van der Veen S., Merello M., Tijssen M.A.J., van de Warrenburg B. Myoclonus-ataxia syndromes: a diagnostic approach. Mov. Disord. Clin. Pract. 2020;8(1):9–24. doi: 10.1002/mdc3.13106

18. Saini L., Dhawan S.R., Madaan P., Suthar R., Saini A.G., Sahu J.K., Sankhyan N. Infection-associated opsoclonus : a retrospective case record analysis and review of literature. J. Child. Neurol. 2020;35(7):480–484. doi: 10.1177/0883073820911327

19. Mitoma H., Manto M. Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms. J. Neurol. 2024;271(10):7046–7053. doi: 10.1007/s00415-024-12596-7

20. Rossor T., Yeh E.A., Khakoo Y., Angelini P., Hemingway C., Irani S.R., Schleiermacher G., Santosh P., Lotze T., Dale R.C., … OMS Study Group. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol. Neuroimmunol. Neuroinflamm. 2022;9(3):e1153. doi: 10.1212/NXI.0000000000001153

21. Yıldırım M., Öncel İ., Bektaş Ö., Tanalı G., Şahin S., Kutluk T., Teber S., Anlar B. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome. Eur. J. Paediatr. Neurol. 2022;41:19–26. doi: 10.1016/j.ejpn.2022.09.002

22. Haden S.V., McShane M.A., Holt C.M. Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticus. Arch. Dis. Child. 2009;94(11):897–899. doi: 10.1136/adc.2009.160044

23. Sakuma H., Shimizu Y., Saito Y., Sugai K., Inagaki M., Kaga M., Sasaki M. Electrophysiological evidence of cerebral dysfunction in childhood opsoclonus-myoclonus syndrome. Mov. Disord. 2010;25(7):940–945. doi: 10.1002/mds.23084

24. Manto M., Triarhou L.C. Ocular dysmetria, flutter, and opsoclonus: refining the oculomotor deficits in cerebellar patients. Cerebellum. 2023;22(4):506–526. doi: 10.1007/s12311-022-01444-x

25. Paliwal V.K., Chandra S., Verma R., Kalita J., Misra U.K. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis? J. Neural. Transm. (Vienna). 2010;117(5):613–615. doi: 10.1007/s00702-010-0366-y

26. Zouari R., Bouchaala W., Nsir S.B., Kamoun F., Triki C. Opsoclonus myoclonus induced by lamotrigine toxicity. Seizure. 2021;91:247–250. doi: 10.1016/j.seizure.2021.06.021

27. Malevich O.B., Il’ina E.S., Homyakova S.P., Kachanov D.Yu., Shamanskaya T.V., Lochmatova M.E., Varfolomeeva S.R. Opsoclonus–myoclonus syndrome in children with neurogenic tumors: a view of a neurologist. Pediatriya = Pediatria. 2019;98(2):221–226. [In Russian]. doi: 10.24110/0031-403X-2019-98-2-221-226


Review

Views: 77


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2410-2512 (Print)
ISSN 2410-2520 (Online)